respiratory Flashcards
what cell type releases inflammatory mediators in the allergic response?
a) neutrophils
b) mast cells
c) antigen presenting cells
d) B cells
e) T cells
mast cells
which antibody Is involved in the allergic response?
a) IgG
b) IgA
c) IgM
d) IgE
e) IgD
IgE
which inflammatory factor released by mast cells is a major therapeutic target in allergies?
a) histamine
b) cox2
c) IL-6
d) TNF
e) IL-1
histamine
which adrenergic receptor do SABA target?
a) alpha 1
b) alpha 2
c) beta 1
d) beta 2
e) beta 3
Beta 2
what is the purpose of budesonide and formoterol when used in a MART regime?
Budesonide is an inhaled corticosteroid. It is a preventer that provides long term control.
Formoterol is a LABA. It is a reliever, it relieves symptoms for longer durations than a SABA and provides bronchodilation. It is given multiple times a day.
a 58 yr female admitted to hospital with acute severe asthma. which of the following meds would NOT be considered as part of acute severe asthma management?
a) hydrocortisone (IV)
b) ipatropium (ICS)
c) prednisolone (OC)
d) salbutamol (SABA)
e) salmetarol (LABA)
salmeterol (LABA)
33 yr pt admitted to hospital with asthma attack. peak flow is 280L/min (best 600L/min) and on admission, HR was 98bpm, RR was 22bpm and oxygen saturation 96%. what is the severity? what would be initial tx for pt?
acute severe asthma; peak flow is 33-50% of best (46%)
tx:
1. SABA; salbutamol 2.5-5mg via nebulizer (hospital)
2. prednisolone 30mg OD for 5 days
if pef 33-50% of best, HR > 110bpm, RR > 25bpm, can’t complete sentences in one breath (only one needs to be present)
destruction of the alveoli walls is mostly associated with which lung condition?
a) asthma
b) cystic fibrosis
c) emphysema
d) chronic bronchitis
e) acute bronchitis
emphysema
bronchial fibrosis and mucus production is mostly associated with which lung condition?
a) asthma
b) cystic fibrosis
c) emphysema
d) chronic bronchitis
e) acute bronchitis
chronic bronchitis
72 yr pt fully adherent to their meds but experiencing inc breathlessness and sputum production over last 6 months. no evidence of asthmatic features and blood eosinophils are insignificantly raised.
currently they take 100mcg/puff 2 puffs PRN and inc ellipse (umeclidinium bromide) 1 puff OD
what would be a step up therapy?
a) fostair NEXThaler (formoterol/beclomethasone)
b) relvar eleita (fluticasone/vilanterol)
c) seebri breezehaler (glycopyrronium bromide)
d) spoilto Respimat (tiotropium/olodaterol)
e) trilogy ellipta (fluticasone/vilanterol/umeclidinium bromide)
spiolto Respimat (tiotropium/olodaterol)
48 yr pt w COPD inc breathlessness + sputum production. Suffering from worsening symptoms for 3 days. sputum is purulent + bright green. Basic observations show temp 38.5 degrees. you diagnose pt with infective exacerbation of COPD and had rash after taking amoxicillin.
what is the 1st line antibiotic?
a) amoxicillin
b) clarithromycin
c) doxycycline
d) ciprofloxacin
e) nitrofurantoin
doxycycline
which of these observations are abnormal?
a) bp 148/82mmHg
b) pulse rate: 98 bpm
c) oxygen saturations: 96%
d) RR: 19bpm
e) temp: 37.3 degrees
bp 148/82mmHg
120/80mmHg
which of the following would NOT be a typical feature of otitis media?
a) bulging tympanic membrane when viewed using an otoscope
b) discharge from the ear canal
c) ear tugging
d) otalgia
e) temp of 37.7
discharge from the ear canal
bec otitis externa
27 yrs with ear pain for 24 hours. You diagnose with acute otitis external.
a) describe the general observations that would have been noted and the findings seen during the ear examination to confirm otitis externa.
b) what tx would you recommend?
a) fluid discharge, swelling + redness of ear canal, eczematous style rash on outside of ear, hearing loss
b) acetic acid spray (ear calm), pain relief, referral if bacterial infection (foul smelling discharge)
48 yrs breathlessness + productive cough over 2 days. Pain in chest when breathing in/out, not delerious. Temp 38.2, bp 108/92mmHg, RR of 21bpm, HR 98bpm. Suspecting CAP and refer to GP.
what score of CRB-65 tool?
a) 0
b) 1
c) 2
d) 3
e) 4
0